Research has shown that infection and inflammation play a role in 15% to 20% of all cancers, and that “highly prevalent” oral diseases are “significantly

In back-to-back papers published July 28 in Science, researchers from the Broad Institute, Dana-Farber Cancer Institute, Johns Hopkins Kimmel Cancer Center, the University of Pittsburgh,

There is no significant association between bone fluoride levels and osteosarcoma risk, according to a new study in the Journal of Dental Research (July 28,

LED Dental has released a camera system to complement VELscope Vx, designed to help detect and document abnormal mucosal tissue. After shining the VELscope’s blue

Cancer Research U.K. has launched a large, multicenter trial to test a new device for detecting Barrett’s esophagus, a condition that puts sufferers at increased

Participating in a community-based head and neck cancer screening clinic can help reduce tobacco use in at-risk populations, according to a study published online July

CEL-SCI has expanded its licensing agreement with Teva Pharmaceutical Industries for its cancer drug Multikine, CEL-SCI’s investigational phase III drug for the treatment of head

Using tumor-targeted nanoparticles to deliver high doses of anticancer agents directly to head and neck tumors increases survival while triggering fewer side effects, according to

The OralCDx (Oral Cancer Prevention International) brush test demonstrated high sensitivity and specificity values in diagnosing and monitoring oral leukoplakia, according to a study in

The U.S. Food and Drug Administration has approved a national clinical trial to study the safety and effectiveness of a drug treatment on patients receiving

With the alarming rise in the rate of oropharyngeal cancer among men being linked to the human papillomavirus (HPV), the U.S. Centers for Disease Control